Molecular Genetics of ADH/DCIS and ALH/LCIS

Breast Pathology: A Volume in Foundations in Diagnostic Pathology Series

Volumn , Issue , 2006, Pages 185-189

  Reis Filho, Jorge S ^a   Lakhani, Sunil R ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350465773     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06680-1.50023-5     Document Type: Chapter

References (26)

1. Cleton-Jansen AM E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?. Breast Cancer Res 2002, 4:5-8.
2. Jeffrey SS, Pollack JR The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Breast Cancer Res 2003, 5:320-328.
3. O'Connell P Genetic and cytogenetic analyses of breast cancer yield different perspectives of a complex disease. Breast Cancer Res Treat 2003, 78:347-357.
4. Reis-Filho JS, Lakhani SR The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003, 5:313-319.
5. Shackney SE, Silverman JF Molecular evolutionary patterns in breast cancer. Adv Anat Pathol 2003, 10:278-290.
6. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR Molecular evolution of breast cancer. J Pathol 2005, 205:248-254.
7. Buerger H, Otterbach F, Simon R, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast - evidence of multiple genetic pathways. J Pathol 1999, 187:396-402.
8. Cleton-Jansen AM, Buerger H, Haar N, et al. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer 2004, 41:109-116.
9. Hwang ES, DeVries S, Chew KL, et al. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 2004, 10:5160-5167.
10. Lakhani SR, Collins N, Stratton MR, Sloane JP Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 1995, 48:611-615.
11. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003, 100:5974-5979.
12. Robanus-Maandag EC, Bosch CA, Kristel PM, et al. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. J Pathol 2003, 201:75-82.
13. Roylance R, Gorman P, Hanby A, Tomlinson I Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol 2002, 196:32-36.
14. Roylance R, Gorman P, Harris W, et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 1999, 59:1433-1436.
15. Stratton MR, Collins N, Lakhani SR, Sloane JP Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 1995, 175:195-201.
16. Waldman FM, DeVries S, Chew KL, Moore DH, et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 2000, 92:313-320.
17. Droufakou S, Deshmane V, Roylance R, et al. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 2001, 92:404-408.
18. Etzell JE, DeVries S, Chew K, et al. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 2001, 32:292-296.
19. Lakhani S, Collins N, Sloane J, Stratton M Loss of heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol: Mol Pathol 1995, 48:M74-M78.
20. Lishman SC, Lakhani SR Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology. Histopathology 1999, 35:195-200.
21. Lu YJ, Osin P, Lakhani SR, et al. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998, 58:4721-4727.
22. Middleton LP, Palacios DM, Bryant BR, et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000, 24:1650-1656.
23. Palacios J, Sarrio D, Garcia-Macias MC, Bryant B, et al. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol 2003, 16:674-678.
24. Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinama of the breast: role of comprehensive molecular pathology in characteri-zation of an entity. J Pathol 2005, 207:1-13.
25. Sarrio D, Moreno-Bueno G, Hardisson D, et al. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 2003, 106:208-215.
26. Simpson PT, Gale T, Fulford LG, et al. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003, 5:258-262.